Kingsview Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $474K | Sell |
|
|||||
|
2025
Q1 | $485K | Sell |
|
|||||
|
2024
Q4 | $572K | Buy |
|
|||||
|
2024
Q3 | $391K | Buy |
|
|||||
|
2024
Q2 | $340K | Buy |
|
|||||
|
2024
Q1 | $332K | Buy |
|
|||||
|
2023
Q4 | $301K | Sell |
|
|||||
|
2023
Q3 | $343K | Sell |
|
|||||
|
2023
Q2 | $460K | Sell |
|
|||||
|
2023
Q1 | $669K | Buy |
|
|||||
|
2022
Q4 | $456K | Sell |
|
|||||
|
2022
Q3 | $503K | Buy |
|
|||||
|
2022
Q2 | $446K | Sell |
|
|||||
|
2022
Q1 | $580K | Buy |
|
|||||
|
2021
Q4 | $694K | Sell |
|
|||||
|
2021
Q3 | $833K | Buy |
|
|||||
|
2021
Q2 | $339K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $4.75M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $3.35M | Buy |
|
|||||
|
2017
Q2 | $2.83M | Buy |
|